Stephanie Nichole Van Dine

Stephanie Van Dine practices at Middle Georgia Heart and Vascular Center in Milledgeville, Georgia.

Stephanie Van Dine's NPI, 1588153498, was assigned on May 7, 2018. Stephanie Van Dine holds Georgia license RN275921.

Stephanie Van Dine's primary practice is Middle Georgia Heart and Vascular Center, at 679 W Martin Luther King Jr Dr, Milledgeville, GA 31061 in Baldwin County. The practice phone is (478) 254-2644.

Stephanie Van Dine's primary practice is Middle Georgia Heart and Vascular Center in Milledgeville, Georgia. Stephanie Van Dine is also affiliated with Atrium Health Navicent Baldwin. The medical group on file is Middle Georgia Heart & Vascular Center. Dmand AI also links Stephanie Van Dine to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Van Dine practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Stephanie Van Dine's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Stephanie Van Dine is licensed in Georgia.

CMS counts 402 Medicare patients who saw Stephanie Van Dine in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Van Dine's median patient age at 69, with 49% women.

In 2024, Stephanie Van Dine wrote 2,729 Medicare Part D claims for 409 patients. 77% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Stephanie Van Dine for performance year 2024, reported individually. Stephanie Van Dine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Stephanie Van Dine from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $144.